Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
Nov 11, 2026, 4:10 PM AEDT
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 24.86 million as of November 10, 2026. It is the 37,878th most valuable company in the world and the 991st biggest in Australia. Its market cap has decreased by 90.29% in one year.
Market Cap
24.86M
Enterprise Value
-10.85M
Revenue
33.80M
Global Rank
Country Rank
#991 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 24.86M, an increase of 102.73%. That is a compound annual growth rate of 7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 24.86M | -90.64% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 43.41M |
| Immutep | 38.32M |
| Nexsen | 32.03M |
| Neurotech International | 30.71M |
| Algorae Pharmaceuticals | 18.25M |
| Miro Sciences | 17.54M |
| Radiopharm Theranostics | 17.35M |
| Imugene | 17.14M |